Replies to post #222972 on Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

If P results are great, psoriasis treatment revenues are over $10B/yr, patent is for nearly 20 yrs, P would be first in class due to cost, oral delivery, and lack of side effects, then how do you arrive at a pittance of $1B+ as a proper valuation?

If the BP is going to get revenues over its lifetime of over $100B or so does it sound proper for IPIX to get $1B for developing the drug?

Today makes one realize how tiny in the overall scheme of things (as in eternity) our investments really are. Sure would like to see our drugs help a whole heck of a lot of people, though, and wish all our drugs were already available (even if not FDA approved) to those that would request them.

[frrol]

At the moment, there's a very broad potential range for IPIX future value. It could be $200M to $20B. It all depends on trial results, FDA conclusions, and BP appetites. In my post I am referring to buyout negotiations around a hypothetical example that assumes a PV of around $1B. That hypothetical PV is not based on any NPV calculation.

I do think we are undervalued here, even if P is a bust. Of course that doesn't mean the stock couldn't go lower. My vote is just one of many in the public securities market.

[BooDog]

Very much looking forward to the next few weeks.

More answers set the value even better. Data for prurisol coming soon.

$IPIX